Vesicular neurotransmitter transporters

@article{Varoqui2007VesicularNT,
  title={Vesicular neurotransmitter transporters},
  author={Hélène Varoqui and Jeffrey D. Erickson},
  journal={Molecular Neurobiology},
  year={2007},
  volume={15},
  pages={165-191}
}
Neurotransmission depends on the regulated release of chemical transmitter molecules. This requires the packaging of these substances into the specialized secretory vesicles of neurons and neuroendocrine cells, a process mediated by specific vesicular transporters. The family of genes encoding the vesicular transporters for biogenic amines and acetylcholine have recently been cloned. Direct comparison of their transport characteristics and pharmacology provides information about vesicular… 
Molecular, Structural, Functional, and Pharmacological Sites for Vesicular Glutamate Transporter Regulation
TLDR
This review provides an overview of the physiologic sites for VGLUT regulation that could modulate glutamate release in an over-active synapse or in a disease state.
Physiopathological Role of the Vesicular Nucleotide Transporter (VNUT) in the Central Nervous System: Relevance of the Vesicular Nucleotide Release as a Potential Therapeutic Target
TLDR
The physiological relevance of the vesicular nucleotide transport in the central nervous system is analyzed and the possible role of VNUT in the development of some pathological processes, such as chronic neuropathic pain or glaucoma is discussed.
Vesicular neurotransmitter transporter trafficking in vivo: Moving from cells to flies
TLDR
In vivo studies of DVMAT trafficking mutants will allow us to determine how changes in the localization of vesicular transporters affect the nervous system as a whole and complex behaviors mediated by aminergic circuits.
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease
TLDR
The importance of DAT and VMAT2 function in the delicate balance of neuronal dopamine is reviewed, with a new focus on the importance of transporter proteins as both models of human disease and potential drug targets has emerged.
Sorting of the Vesicular GABA Transporter to Functional Vesicle Pools by an Atypical Dileucine-like Motif
TLDR
Real-time imaging with a VGAT-pHluorin fusion provides a useful approach to explore how unique sorting sequences target individual proteins to synaptic vesicles with distinct functional properties.
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
TLDR
This review provides an overview of the current understanding of DAT and VMAT2 neurobiology, including discussion of studies ranging from those conducted in vitro to those involving human subjects and how selected drugs alter the function and expression of these transporters.
Glutamate Cotransmission in Cholinergic, GABAergic and Monoamine Systems: Contrasts and Commonalities
TLDR
An overview of glutamate cotransmission in these different classes of neurons is provided, highlighting puzzling differences in the proportion of such neurons expressing a VGLUT in different brain regions and at different stages of development.
From glutamate co-release to vesicular synergy: vesicular glutamate transporters
TLDR
Questions are raised about the morphological and functional organization of neuronal systems endowed with such a dual signalling capacity and the behavioural relevance of this co-phenotype is presently the focus of considerable interest.
...
...

References

SHOWING 1-10 OF 235 REFERENCES
Differential expression of two vesicular monoamine transporters
TLDR
Although adrenal chromaffin cells, sympathetic and enteric neurons derive from the neural crest, they express different vesicular amine transporters, these findings are consistent with the functional characteristics of VMAT1 and VMAT2 and help to explain several classic pharmacological observations.
Expression of the vesicular acetylcholine transporter in mammalian cells.
Molecular cloning of a putative vesicular transporter for acetylcholine.
TLDR
Observations support a role for rVAChT in vesicular ACh transport and indicate its potential as a novel marker for cholinergic neurons.
The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
TLDR
Direct evidence is provided that a single VMAT is expressed in two morphologically distinct types of regulated secretory vesicles in central monoaminergic neurons.
Mechanism of transport and storage of neurotransmitters.
TLDR
This review will focus on the bioenergetics, mechanism, and molecular basis of neurotransmitter transport, and the sodium-coupled and proton coupled systems, which play an important role in the overall process of synaptic transmission.
Mechanism of Transport and Storage of Neurotransmitter
TLDR
This review will focus on the bioenergetics, mechanism, and molecular basis of neurotransmitter transport, and the sodium-coupled and proton coupled systems, which play an important role in the overall process of synaptic transmission.
Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells
TLDR
To localize the transporter that packages monoamines into secretory vesicles, antibodies are raised to a COOH- terminal sequence from the vesicular amine transporter expressed in the adrenal gland (VMAT1), indicating that VMAT1 provides a novel membrane protein marker unique to LDCVs.
...
...